年内吸金超20亿元！港股创新药50ETF（513780）盘中涨超2%，机构9月看好创新药赛道

格隆汇09-02

港股创新药今日领涨，百济神州涨超8%，带动港股创新药50ETF（513780）涨超2%。今年是港股创新药爆发之年，港股创新药50ETF（513780）年内涨幅超112%，领涨ETF市场。港股创新药上涨之际，资金借道ETF持续流入。港股创新药50ETF（513780）近20日资金净流入额8亿元，年内资金净流入超20亿元，最新规模27.12亿元，同指数规模最大、流动性最好的产品，可T+0交易 ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2564824853?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-02 10:22","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2564824853","market":"sh","top_or_hot":-1,"title":"年内吸金超20亿元！港股创新药50ETF（513780）盘中涨超2%，机构9月看好创新药赛道","media":"格隆汇","content":"<div>\n<p>港股创新药今日领涨，百济神州涨超8%，带动港股创新药50ETF（513780）涨超2%。\n今年是港股创新药爆发之年，港股创新药50ETF（513780）年内涨幅超112%，领涨ETF市场。\n港股创新药上涨之际，资金借道ETF持续流入。港股创新药50ETF（513780）近20日资金净流入额8亿元，年内资金净流入超20亿元，最新规模27.12亿元，同指数规模最大、流动性最好的产品，可T+0交易\n...</p>\n\n<a href=\"https://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n","source":"live_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>年内吸金超20亿元！港股创新药50ETF（513780）盘中涨超2%，机构9月看好创新药赛道</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n年内吸金超20亿元！港股创新药50ETF（513780）盘中涨超2%，机构9月看好创新药赛道\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-02 10:22 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/rss/live/live.xml><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>港股创新药今日领涨，百济神州涨超8%，带动港股创新药50ETF（513780）涨超2%。\n今年是港股创新药爆发之年，港股创新药50ETF（513780）年内涨幅超112%，领涨ETF市场。\n港股创新药上涨之际，资金借道ETF持续流入。港股创新药50ETF（513780）近20日资金净流入额8亿元，年内资金净流入超20亿元，最新规模27.12亿元，同指数规模最大、流动性最好的产品，可T+0交易\n...</p>\n\n<a href=\"https://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"https://www.gelonghui.com/rss/live/live.xml","article_id":"2564824853","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564824853","pubTimestamp":1756779759,"columns":[],"sourceInfo":{"source_id":"live_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"港股创新药今日领涨，百济神州涨超8%，带动港股创新药50ETF（513780）涨超2%。\n今年是港股创新药爆发之年，港股创新药50ETF（513780）年内涨幅超112%，领涨ETF市场。\n港股创新药","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159858":"创新药指","159992":"创新药","513780":"港股创新药50ETF","600030":"中信证券","603259":"药明康德","688235":"百济神州","01801":"信达生物","BK1564":"中资券商股","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","02359":"药明康德","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","BK1576":"医药外包概念","02269":"药明生物","BK0276":"资本市场","01093":"石药集团","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK1593":"医美概念股","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","ONC":"百济神州","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","09926":"康方生物","FDN":"First Trust Dow Jones Internet I","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","06030":"中信证券","BK4585":"ETF&股票定投概念","IE0008369823.USD":"FSSA HONG KONG GROWTH \"I\" ACC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","01477":"欧康维视生物-B","HSCEI":"国企指数","07226":"南方两倍做多恒科","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","01530":"三生制药","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","06160":"百济神州","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","HSTECH":"恒生科技指数","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU1152091754.HKD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" (HKD) INC","06978":"永泰生物-B","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","YANG":"三倍做空富时中国ETF-Direxion","BK4588":"碎股","01177":"中国生物制药","LU0181495838.USD":"施罗德新兴亚洲A Acc"},"translate_title":"During the year, it attracted more than 2 billion yuan! Hong Kong stock innovative drug 50ETF (513780) rose more than 2% intraday, institutions are optimistic about the innovative drug track in September","themeId":"9e120cbc689472c9ad07159548b432a1","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159858":1,"159992":1,"513780":1,"600030":1,"603259":1,"688235":1,"HSCEI":1,"YANG":1,"HSTECH":1,"07226":1,"06030":1,"01801":1,"02269":1,"06978":1,"09926":1,"01093":1,"06160":1,"01177":1,"01530":1,"ONC":1,"02359":1,"FDN":1,"01477":1},"content_text":"港股创新药今日领涨，百济神州涨超8%，带动港股创新药50ETF（513780）涨超2%。\n今年是港股创新药爆发之年，港股创新药50ETF（513780）年内涨幅超112%，领涨ETF市场。\n港股创新药上涨之际，资金借道ETF持续流入。港股创新药50ETF（513780）近20日资金净流入额8亿元，年内资金净流入超20亿元，最新规模27.12亿元，同指数规模最大、流动性最好的产品，可T+0交易\n港股创新药50ETF（513780）及联接基金A/C（023597/023598）跟踪的指数是中证港股通创新药指数，成份股比较纯粹，只包括创新药公司，重仓股包括康方生物、信达生物、药明生物、百济神州、中国生物制药、石药集团、瀚森制药、药明康德、三生制药等行业龙头公司。\n中信证券指出，9月创新药催化事件料将明显增多，同时近期的科技切换也出清了此前囤积在板块当中追逐趋势的短钱，创新药在此轮调整后有望继续上行。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2564824853","isCrawlerRequest":true}